companydata.dkShire Biotech Denmark ApS: Financial statements 2012
CVR: 33358008
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 4,145,110 and a net result of DKK 92,990. The profit margin was 2.2%. Equity amounted to DKK 328,769. The solvency ratio was 5.7%.
- Revenue
- 4,145,110 kr.
- Gross Profit
- 4,145,110 kr.
- Profit/Loss
- 92,990 kr.
- Equity
- 328,769 kr.
- Total Assets
- 5,787,081 kr.
How creditworthy is Shire Biotech Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of May 22, 2012, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Shire Biotech Denmark ApS.
As of May 22, 2012, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of Shire Biotech Denmark ApS.
As of February 3, 2012, Mary Christine Di Marzio has joined the board of directors of Shire Biotech Denmark ApS.
As of February 3, 2012, Lars Eric Jernestahl has left the board of directors of Shire Biotech Denmark ApS.
As of February 3, 2012, Mary Christine Di Marzio is registered as direktion of Shire Biotech Denmark ApS.
As of February 3, 2012, Lars Eric Jernestahl has stepped down as direktion of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010 and dissolved in 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity amounted to DKK 3,207,794.